Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia

Essential thrombocythemia, as defined by the WHO in 2016, is a Philadelphia-negative chronic myeloproliferative neoplasm showing a better prognosis than polycythemia vera and myelofibrosis. In a variable percentage, patients with essential thrombocythemia show none of the known driver-gene mutations...

Descripción completa

Detalles Bibliográficos
Autores principales: Santoro, Marco, Accurso, Vincenzo, Mancuso, Salvatrice, Napolitano, Mariasanta, Mattana, Marta, Vajana, Giorgia, Russello, Federica, Siragusa, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498770/
https://www.ncbi.nlm.nih.gov/pubmed/36135321
http://dx.doi.org/10.3390/hematolrep14030037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498770/
https://www.ncbi.nlm.nih.gov/pubmed/36135321
http://dx.doi.org/10.3390/hematolrep14030037

Ejemplares similares